Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 76

1.

Ossifying Fibromyxoid Tumor: a study of 6 cases of atypical and malignant variants.

Dantey K, Schoedel K, Yergiyev O, McGough R, Palekar A, Rao UN.

Hum Pathol. 2016 Nov 2. pii: S0046-8177(16)30283-0. doi: 10.1016/j.humpath.2016.10.012. [Epub ahead of print]

PMID:
27816723
2.

CDK8 Expression in Extrauterine Leiomyosarcoma Correlates With Tumor Stage and Progression.

Yergiyev O, Garib G, Schoedel K, Palekar A, Bartlett D, Rao UN.

Appl Immunohistochem Mol Morphol. 2016 Jul 6. [Epub ahead of print]

PMID:
27389556
3.

Correlation of Classic and Molecular Cytogenetic Alterations in Soft-Tissue Sarcomas: Analysis of 46 Tumors With Emphasis on Adipocytic Tumors and Synovial Sarcoma.

Rao UN, Cieply K, Sherer C, Surti U, Gollin SM.

Appl Immunohistochem Mol Morphol. 2016 Jan 22. [Epub ahead of print]

PMID:
26808135
4.

Tumor associated PD-L1 expression pattern in microscopically tumor positive sentinel lymph nodes in patients with melanoma.

Tarhini AA, Zahoor H, Yearley JH, Gibson C, Rahman Z, Dubner R, Rao UN, Sander C, Kirkwood JM.

J Transl Med. 2015 Sep 30;13:319. doi: 10.1186/s12967-015-0678-7.

5.

Intermediate-grade meningeal melanocytoma associated with nevus of Ota: a case report and review of the literature.

Shin D, Sinha M, Kondziolka DS, Kirkwood JM, Rao UN, Tarhini AA.

Melanoma Res. 2015 Aug;25(4):273-8. doi: 10.1097/CMR.0000000000000163. Review.

PMID:
25933209
6.

Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotype.

Paraiso KH, Das Thakur M, Fang B, Koomen JM, Fedorenko IV, John JK, Tsao H, Flaherty KT, Sondak VK, Messina JL, Pasquale EB, Villagra A, Rao UN, Kirkwood JM, Meier F, Sloot S, Gibney GT, Stuart D, Tawbi H, Smalley KS.

Cancer Discov. 2015 Mar;5(3):264-73. doi: 10.1158/2159-8290.CD-14-0293.

7.

Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial.

Hodi FS, Lee S, McDermott DF, Rao UN, Butterfield LH, Tarhini AA, Leming P, Puzanov I, Shin D, Kirkwood JM.

JAMA. 2014 Nov 5;312(17):1744-53. doi: 10.1001/jama.2014.13943.

8.

First-in-man study of western reserve strain oncolytic vaccinia virus: safety, systemic spread, and antitumor activity.

Zeh HJ, Downs-Canner S, McCart JA, Guo ZS, Rao UN, Ramalingam L, Thorne SH, Jones HL, Kalinski P, Wieckowski E, O'Malley ME, Daneshmand M, Hu K, Bell JC, Hwang TH, Moon A, Breitbach CJ, Kirn DH, Bartlett DL.

Mol Ther. 2015 Jan;23(1):202-14. doi: 10.1038/mt.2014.194.

9.

Immunohistochemical analysis of expressions of RB1, CDK4, HSP90, cPLA2G4A, and CHMP2B is helpful in distinction between myxofibrosarcoma and myxoid liposarcoma.

Wang T, Goodman MA, McGough RL, Weiss KR, Rao UN.

Int J Surg Pathol. 2014 Oct;22(7):589-99. doi: 10.1177/1066896914532539.

PMID:
24788530
10.

Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab.

Tarhini AA, Edington H, Butterfield LH, Lin Y, Shuai Y, Tawbi H, Sander C, Yin Y, Holtzman M, Johnson J, Rao UN, Kirkwood JM.

PLoS One. 2014 Feb 3;9(2):e87705. doi: 10.1371/journal.pone.0087705.

11.

Primary intraosseous schwannoma in tibial epiphysis with unique immunohistochemical phenotype: a case report.

Wang T, Giugale JM, Ding M, Goodman MA, Schoedel K, Rao UN.

Int J Surg Pathol. 2014 Sep;22(6):574-8. doi: 10.1177/1066896913511984.

PMID:
24326824
12.

Melanoma-associated leukoderma - immunology in black and white?

Naveh HP, Rao UN, Butterfield LH.

Pigment Cell Melanoma Res. 2013 Nov;26(6):796-804. doi: 10.1111/pcmr.12161. Review.

13.

Distinct profiles of oxidative stress-related and matrix proteins in adult bone and soft tissue osteosarcoma and desmoid tumors: a proteomics study.

Rao UN, Hood BL, Jones-Laughner JM, Sun M, Conrads TP.

Hum Pathol. 2013 May;44(5):725-33. doi: 10.1016/j.humpath.2012.06.023.

PMID:
23063503
14.

Immunohistochemical analysis of the endoribonucleases Drosha, Dicer and Ago2 in smooth muscle tumours of soft tissues.

Papachristou DJ, Sklirou E, Corradi D, Grassani C, Kontogeorgakos V, Rao UN.

Histopathology. 2012 May;60(6B):E28-36. doi: 10.1111/j.1365-2559.2012.04192.x.

PMID:
22394132
15.

Prognostic significance of Dicer cellular levels in soft tissue sarcomas.

Papachristou DJ, Rao UN, Korpetinou A, Giannopoulou E, Sklirou E, Kontogeorgakos V, Kalofonos HP.

Cancer Invest. 2012 Feb;30(2):172-9. doi: 10.3109/07357907.2011.633293.

PMID:
22149178
16.

Prostatic adenocarcinoma metastatic to pleomorphic liposarcoma, a "collision phenomenon": report of a case with review of pelvic collision tumors.

Roy S, Hrebinko RL, Cieply KM, Parwani AV, Rao UN.

Patholog Res Int. 2011;2011:173541. doi: 10.4061/2011/173541.

17.

AIDS-Related EBV-Associated Smooth Muscle Tumors: A Review of 64 Published Cases.

Purgina B, Rao UN, Miettinen M, Pantanowitz L.

Patholog Res Int. 2011 Mar 10;2011:561548. doi: 10.4061/2011/561548.

18.

Extraskeletal osteosarcoma of subcutaneous soft tissue with lymph node and skin metastasis: a case report with fluorescence in situ hybridization analysis.

Papachristou DJ, Goodman M, Cieply K, Rao UN.

Pathol Oncol Res. 2012 Jan;18(1):107-10. doi: 10.1007/s12253-010-9349-4. No abstract available.

PMID:
21229341
19.

Sox9 expression is not limited to chondroid neoplasms: variable occurrence in other soft tissue and bone tumors with frequent expression by synovial sarcomas.

Cajaiba MM, Jianhua Luo, Goodman MA, Fuhrer KA, Rao UN.

Int J Surg Pathol. 2010 Oct;18(5):319-23. doi: 10.1177/1066896910367650.

PMID:
20484142
20.

Pharmacodynamic (phase 0) study using etaracizumab in advanced melanoma.

Moschos SJ, Sander CA, Wang W, Reppert SL, Drogowski LM, Jukic DM, Rao UN, Athanassiou C, Buzoianu M, Mandic M, Richman L, McKinney L, Leininger J, Tice DA, Hammershaimb L, Kirkwood JM.

J Immunother. 2010 Apr;33(3):316-25. doi: 10.1097/CJI.0b013e3181c1f216.

PMID:
20445352
Items per page

Supplemental Content

Support Center